Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 06, 2016 11:02 AM ET

Biotechnology

Company Overview of Arbutus Biopharma Corporation

Executive Profile

Keith S. Manchester M.D.

Independent Director and Chairman of Corporate Governance & Nominating Committee, Arbutus Biopharma Corporation
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
46--

Background

Dr. Keith S. Manchester, M.D. served as a Vice President of Business Development of Applied Molecular Evolution, Inc., from January 2002 to 2004. From 2000 to 2002, Dr. Manchester served as Director of Business Development in Applied Molecular Evolution Inc. From 1999 to 2000, he was an Associate at Vestar Capital Partners. From 1997 to 1999, he was an investment banker in the healthcare group at Goldman, Sachs & Co. He completed his surgical internship at Parkland Medical ...

Corporate Headquarters

100-8900 Glenlyon Parkway
Burnaby, British Columbia V5J 5J8

Canada

Phone: 604-419-3200
Fax: 604-419-3201

Board Members Memberships

Director
Independent Director and Chairman of Corporate Governance & Nominating Committee

Education

BA
Harvard College
MD
Harvard Medical School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ali Mortazavi Chief Executive and Director
Silence Therapeutics plc
$200.0K
Gregory West CAInterim Chief Executive Officer, Chief Financial Officer and Company Secretary
Benitec Biopharma Limited
$230.0K
Mark W. Schwartz Ph.D.Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee
Galena Biopharma, Inc.
$707.1K
Paul C. Grint M.D.Chief Executive Officer, President and Director
Regulus Therapeutics Inc.
--
Douglas M. Fambrough III, Ph.D.Co-Founder, Chief Executive Officer, President and Director
Dicerna Pharmaceuticals, Inc.
$430.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Arbutus Biopharma Corporation, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.